Trial Profile
A Safety and Tolerability Study of Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Nov 2013
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Dementia
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb; Otsuka Pharmaceutical Development & Commercialization
- 09 Nov 2004 New trial record.